Literature DB >> 606454

Suppression of DNA synthesis by Con A-activated human lymphocytes: Stimulation by con A bound to non-T cells unless removed after activation.

G C De Gast, T H The, E Ponds, C Kallenberg.   

Abstract

The capacity of human peripheral blood lymphocytes to suppress DNA synthesis of other lymphocytes was studied in an assay consisting of two steps: firstly, activation by Con A during 24 hr followed by alpha-methylglucoside and mitomycin treatment; secondly, incubation of these Con A-activated 'suppressor' cells with autologous responder cells and stimulants, or incubation with allogeneic responder cells. The results were compared with cells similarly treated but not incubated with Con A. If alpha-methylglucoside treatment is omitted, stimulation of T and non-T cells occurs by Con A bound to the Con A-activated cells. Con A is especially bound to non-T lymphocytes and even gives a T cell-independent proliferation of non-T cells without differentiation to plasma cells. With alpha-methylglucoside treatment, 'suppressor' cells, activated by high Con A concentrations, are able to suppress DNA synthesis of autologous lymphocytes stimulated by allogeneic cells or soluble antigens to about 50%. In a one-way MLC, in which the cell suspension containing the suppressor cells is also used as a stimulator cell suspension, a similar suppression was observed. Suppression of DNA synthesis was correlated with suppression of proliferation without evidence of cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 606454      PMCID: PMC1541143     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Concanavalin A-activated suppressor cells in normal human peripheral blood lymphocytes.

Authors:  C Hubert; G Delespesse; A Govaerts
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

2.  Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia.

Authors:  T A Waldmann; M Durm; S Broder; M Blackman; R M Blaese; W Strober
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

3.  The splenic suppressor cell. II. Suppression of mixed lymphocyte reaction by thymus-dependent adherent cells.

Authors:  H Folch; B H Waksman
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

4.  Non-specific cytotoxicity by T cells activated with plant mitogens in vitro and the requirement for plant agents during the killing reaction.

Authors:  G L Asherson; J Ferluga; G Janossy
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

5.  T-lymphocyte number and function and the course of hepatitis B in hemodialysis patients.

Authors:  G C De Gast; B Houwen; G K van der Hem; T H The
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

6.  Differing mechanisms of tolerance and desensitization to dinitrochlorobenzene in guinea pigs.

Authors:  L Polak; H Geleick
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

7.  Hodgkin's disease. An immunodepleting and immunosuppressive disorder.

Authors:  J J Twomey; A H Laughter; S Farrow; C C Douglass
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

8.  Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia.

Authors:  R Hoffman; E D Zanjani; J D Lutton; R Zalusky; L R Wasserman
Journal:  N Engl J Med       Date:  1977-01-06       Impact factor: 91.245

9.  Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.

Authors:  D L Peavy; C W Pierce
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  8 in total

1.  Relative ability to provide help: an explanation for Con A-induced suppression.

Authors:  J Farrant; C Newton
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

Review 2.  The use of concanavalin A to study the immunoregulation of human T cells.

Authors:  J M Dwyer; C Johnson
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

3.  Kinetics of mitogen-induced proliferation and differentiation of human peripheral blood B lymphocytes.

Authors:  T V Shankey; R P Daniele; P C Nowell
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

4.  Altered regulation of mitogen responsiveness by suppressor cells in multiple sclerosis.

Authors:  R L Gonzalez; P C Dau; L E Spitler
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

5.  Suppression of DNA synthesis by con A-activated human lymphocytes: role of monocytes in con A-induced suppression.

Authors:  C G Kallenberg; G C de Gast; T H The
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

6.  Con A-induced suppressor cells in children with acute lymphoblastic leukaemia.

Authors:  M Eibl; P Krepler; W Schmidmeier; C Zielinski; H Winterleitner
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

7.  Bovine con A-induced suppressor cells: generation, macrophage requirements and possible mechanisms of regulatory action.

Authors:  W G Smith; W R Usinger; G A Splitter
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

8.  Subpopulations of T lymphocytes and non-specific suppressor cell activity in patients with atopic dermatitis.

Authors:  J R Jensen; M Cramers; K Thestrup-Pedersen
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.